According to Infant Bacterial Therapeutics AB's latest financial reports the company's current EPS (TTM) is -ยฃ0.43. In 2024 the company made an earnings per share (EPS) of -ยฃ0.70 a decrease over its 2023 EPS that were of -ยฃ0.69.